XML 23 R7.htm IDEA: XBRL DOCUMENT v3.23.3
STATEMENTS OF CONDENSED CONSOLIDATED CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net income $ 1,233,097 $ 67,103
Adjustments to reconcile net income to net cash provided by operating activities:    
Deferred income tax expense (benefit) 227,701 (14,229)
Depreciation and depletion 1,230,255 1,269,936
Impairment of long-lived assets and loss/gain on sale/exchange of long-lived assets 40,104 280,026
(Income) loss from investments (5,310) 14,331
(Gain) loss on debt extinguishment (55) 139,085
Share-based compensation expense 38,179 33,706
Distribution of earnings from equity method investments 18,073 38,750
Amortization, accretion and other 12,022 24,937
(Gain) loss on derivatives (1,167,144) 5,550,028
Net cash settlements received (paid) on derivatives 625,051 (4,672,998)
Net premiums (paid) received on derivative instruments (231,343) 13,809
Changes in other assets and liabilities:    
Accounts receivable 1,122,843 (507,050)
Accounts payable (515,879) 343,925
Other current assets 91,946 (27,960)
Other items, net (165,076) (151,641)
Net cash provided by operating activities 2,554,464 2,401,758
Cash flows from investing activities:    
Capital expenditures (1,485,898) (1,047,475)
Cash paid for acquisitions (2,288,201) (150,000)
Proceeds from sale/exchange of assets 4,831 5,394
Proceeds from sale of investment shares 0 189,249
Other investing activities (4,841) (14,306)
Net cash used in investing activities (3,774,109) (1,017,138)
Cash flows from financing activities:    
Proceeds from revolving credit facility borrowings 313,000 10,242,000
Repayment of revolving credit facility borrowings (313,000) (10,242,000)
Proceeds from Term Loan Facility borrowings 1,250,000 0
Debt issuance costs (5,336) (17,852)
Repayment and retirement of debt (1,014,346) (833,029)
Discounts received (premiums paid) on debt extinguishment 5,313 (135,248)
Dividends paid (162,567) (148,765)
Repurchase and retirement of common stock (201,029) (270,345)
Net (distribution to) contribution from noncontrolling interest (7,322) 4,050
Other financing activities (38,962) (9,853)
Net cash used in financing activities (174,249) (1,411,042)
Net change in cash and cash equivalents (1,393,894) (26,422)
Cash and cash equivalents at beginning of period 1,458,644 113,963
Cash and cash equivalents at end of period $ 64,750 $ 87,541